Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 169 Total
MYMD - MyMD Pharmaceuticals Inc - Stock Price Chart
TickerMYMD [NASD]
CompanyMyMD Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap4.46MEPS (ttm)-9.52
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y67.29%
P/S-EPS next 5Y-
P/B0.43EPS Q/Q-308.10%
Dividend-Sales Q/Q-
Insider Own8.22%Inst Own40.09%
Insider Trans0.00%Inst Trans-78.38%
Short Float7.71%Earnings-
Analyst Recom1.00Target Price32.00
Avg Volume227.15K52W Range1.97 - 65.85
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. It focuses on developing and commercializing the MyMD-1 and SUPERA-CBD therapeutic platforms. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune diseases. Supera-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in Baltimore, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rivard PaulChief Legal OfficerAug 24 '23Buy1.11150,000166,500400,000Aug 24 05:58 PM
Rivard PaulChief Legal OfficerAug 17 '23Buy1.1225,00028,080250,000Aug 18 04:21 PM
NKLA - Nikola Corp - Stock Price Chart
TickerNKLA [NASD, RUT]
CompanyNikola Corp
CountryUSA
IndustryFarm & Heavy Construction Machinery
Market Cap676.65MEPS (ttm)-1.06
P/E-EPS this Y53.47%
Forward P/E-EPS next Y18.67%
PEG-EPS past 5Y-
P/S20.72EPS next 5Y-
P/B1.14EPS Q/Q64.04%
Dividend-Sales Q/Q-32.56%
Insider Own8.59%Inst Own32.25%
Insider Trans0.68%Inst Trans0.04%
Short Float19.87%EarningsMay 07/b
Analyst Recom2.38Target Price1.42
Avg Volume94.64M52W Range0.51 - 3.71
Nikola Corp. engages in the provision of zero-emissions transportation and infrastructure solutions. It designs and manufactures battery-electric and hydrogen-electric vehicles, electric vehicle drivetrains, vehicle components, energy storage systems and hydrogen fueling station infrastructure. The company was founded by Trevor Milton in 2015 and is headquartered in Phoenix, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Girsky Stephen JChief Executive OfficerMay 20 '24Buy0.541,000,000540,0007,243,005May 20 07:27 PM
Worthen Britton M.Chief Legal OfficerMar 05 '24Sale0.68109,98074,852647,449Mar 07 06:59 PM
Pike Joseph R.Chief Human Resources OfficerMar 05 '24Sale0.6875,16251,155429,790Mar 07 06:59 PM
Chan Mary SChief Operating OfficerMar 05 '24Sale0.6824,62716,761546,230Mar 07 06:59 PM
Hoefelmann Dirk OlePresident, EnergyMar 05 '24Sale0.685,1003,471294,900Mar 07 06:59 PM
REVB - Revelation Biosciences Inc - Stock Price Chart
TickerREVB [NASD]
CompanyRevelation Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap2.83MEPS (ttm)-30.78
P/E-EPS this Y-1073.58%
Forward P/E-EPS next Y15.84%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.30EPS Q/Q-104.18%
Dividend-Sales Q/Q-
Insider Own0.18%Inst Own0.47%
Insider Trans-90.44%Inst Trans-76.20%
Short Float1.52%EarningsMay 10/a
Analyst Recom1.00Target Price18.70
Avg Volume92.35K52W Range1.71 - 35.40
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. The company was founded on November 20, 2019 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TIDMARSH GEORGE FDirectorDec 08 '23Sale0.5227,77114,4380Dec 12 04:48 PM
TIDMARSH GEORGE FDirectorOct 16 '23Sale0.6610,9577,24342,096Oct 17 04:12 PM
TIDMARSH GEORGE FDirectorOct 16 '23Sale0.651,8451,19927,771Oct 18 05:15 PM
TIDMARSH GEORGE FDirectorSep 28 '23Sale0.691,42998642,096Oct 02 04:09 PM
TIDMARSH GEORGE FDirectorSep 18 '23Sale0.744,0002,96039,348Sep 18 05:18 PM
VSTM - Verastem Inc - Stock Price Chart
TickerVSTM [NASD]
CompanyVerastem Inc
CountryUSA
IndustryBiotechnology
Market Cap107.27MEPS (ttm)-4.40
P/E-EPS this Y0.32%
Forward P/E-EPS next Y19.70%
PEG-EPS past 5Y24.76%
P/S-EPS next 5Y1.74%
P/B4.28EPS Q/Q-34.31%
Dividend-Sales Q/Q-
Insider Own18.79%Inst Own49.12%
Insider Trans-0.41%Inst Trans-
Short Float3.94%EarningsMay 09/a
Analyst Recom1.00Target Price22.50
Avg Volume514.50K52W Range4.00 - 15.18
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Calkins DanielChief Financial OfficerApr 05 '24Sale10.876658,535Apr 08 04:30 PM
Calkins DanielChief Financial OfficerMar 25 '24Sale12.02253008,541Mar 27 04:30 PM
Calkins DanielChief Financial OfficerMar 20 '24Sale11.07556098,566Mar 21 04:31 PM
Stuglik Brian MDirectorMar 19 '24Sale10.382732,83489,640Mar 20 05:32 PM
Paterson DanPresident and CEOMar 19 '24Sale10.381821,88986,490Mar 20 05:34 PM
EDBL - Edible Garden AG Inc - Stock Price Chart
TickerEDBL [NASD]
CompanyEdible Garden AG Inc
CountryUSA
IndustryFarm Products
Market Cap5.66MEPS (ttm)-47.17
P/E-EPS this Y63.72%
Forward P/E-EPS next Y70.43%
PEG-EPS past 5Y32.73%
P/S0.38EPS next 5Y-
P/B-EPS Q/Q69.11%
Dividend-Sales Q/Q27.58%
Insider Own12.25%Inst Own0.36%
Insider Trans-6.92%Inst Trans-
Short Float5.15%EarningsMay 15/b
Analyst Recom1.00Target Price12.00
Avg Volume1.16M52W Range1.74 - 89.60
Edible Garden AG, Inc. is a controlled environment agriculture (CEA) farming company, which engages in the usage of traditional agricultural growing techniques together with technology to grow organic food. Its products include lettuces, potted herbs, and cut herbs. The company was founded by James E. Kras and Michael C. James on March 28, 2020 and is headquartered in Belvidere, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
UBS Group AG10% OwnerApr 25 '24Buy6.071,0056,10535,077May 03 12:04 PM
UBS Group AG10% OwnerApr 25 '24Sale5.4330,056163,3075,025May 03 12:04 PM
UBS Group AG10% OwnerApr 24 '24Sale6.3010666834,076May 03 12:04 PM
DonAroma PamelaDirectorJun 02 '23Buy1.511,0001,5101,000Jun 06 04:30 PM
DMTK - DermTech Inc - Stock Price Chart
TickerDMTK [NASD]
CompanyDermTech Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap12.24MEPS (ttm)-2.69
P/E-EPS this Y34.05%
Forward P/E-EPS next Y12.90%
PEG-EPS past 5Y-
P/S0.78EPS next 5Y-
P/B0.31EPS Q/Q43.65%
Dividend-Sales Q/Q10.58%
Insider Own8.82%Inst Own13.07%
Insider Trans-0.52%Inst Trans-24.11%
Short Float8.94%EarningsMay 14/a
Analyst Recom2.20Target Price2.28
Avg Volume622.33K52W Range0.31 - 3.90
DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Its products and services include melanoma test, smart sticker, and telemedicine option for melanoma test. The company was founded in 1995 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sun Kevin MChief Financial OfficerDec 11 '23Sale1.45447648277,499Dec 11 08:02 PM
Ibarra ClaudiaChief Operating OfficerDec 11 '23Sale1.45331480193,547Dec 11 08:02 PM
Ibarra ClaudiaChief Operating OfficerDec 08 '23Sale1.412,6073,676193,878Dec 11 08:02 PM
Sun Kevin MChief Financial OfficerDec 07 '23Sale1.534,9797,618277,946Dec 11 08:02 PM
Ibarra ClaudiaChief Operating OfficerDec 07 '23Sale1.533,9115,984196,485Dec 11 08:02 PM
VLD - Velo3D Inc - Stock Price Chart
TickerVLD [NYSE, RUT]
CompanyVelo3D Inc
CountryUSA
IndustryComputer Hardware
Market Cap50.26MEPS (ttm)-0.59
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.82EPS next 5Y17.00%
P/B0.98EPS Q/Q43.01%
Dividend-Sales Q/Q-63.50%
Insider Own30.45%Inst Own18.26%
Insider Trans-0.37%Inst Trans2.23%
Short Float9.22%EarningsMay 15/a
Analyst Recom1.00Target Price2.10
Avg Volume6.80M52W Range0.17 - 2.50
May-15-24 08:54PM VLD Stock Earnings: Velo3D Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:05PM Velo3D Announces First Quarter 2024 Financial Results (Business Wire)
May-11-24 07:11AM What happened to 3D printing stocks? (Insider Monkey)
May-07-24 04:05PM Velo3D to Announce First-Quarter Results on May 15, 2024 (Business Wire)
Apr-22-24 08:30AM Velo3D, Inc. Announces Executive Leadership Changes (Business Wire)
Apr-12-24 04:05PM Velo3D Announces Closing of $12 Million Public Offering (Business Wire)
Apr-11-24 09:00AM Nancy Krystal Joins Velo3D as Vice President, General Counsel (Business Wire) +16.84%
Apr-10-24 08:39AM Velo3D Announces Pricing of $12 Million Public Offering (Business Wire) -38.89%
08:31AM Why Is Velo3D (VLD) Stock Down 23% Today? (InvestorPlace)
Apr-09-24 05:00PM Velo3D Announces Proposed Public Offering (Business Wire)
Velo3D, Inc. operates as technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer, sapphire XC, and SupportFree process. The company was founded by Benyamin Buller in June 2014 and is headquartered Fremont, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kreger Bradley AllenInterim CEOMay 20 '24Sale0.2011,8592,371233,051May 22 04:54 PM
Kreger Bradley AllenInterim CEOMay 15 '24Sale0.2310,7352,475213,464May 17 05:10 PM
Kreger Bradley AllenINTERIM CEOApr 18 '24Sale0.2713,6043,725195,003Apr 22 09:38 PM
Buller BenyaminDirectorMar 28 '24Sale0.432,0008645,020,706Mar 29 09:28 PM
Buller BenyaminDirectorMar 27 '24Sale0.352,0006995,022,706Mar 29 09:28 PM
VLY - Valley National Bancorp - Stock Price Chart
TickerVLY [NASD, RUT]
CompanyValley National Bancorp
CountryUSA
IndustryBanks - Regional
Market Cap3.47BEPS (ttm)0.85
P/E8.03EPS this Y-17.20%
Forward P/E6.44EPS next Y20.47%
PEG1.61EPS past 5Y4.85%
P/S1.00EPS next 5Y5.00%
P/B0.53EPS Q/Q-35.51%
Dividend6.46%Sales Q/Q13.92%
Insider Own15.85%Inst Own64.68%
Insider Trans-0.17%Inst Trans0.19%
Short Float8.27%EarningsApr 25/b
Analyst Recom2.50Target Price9.09
Avg Volume5.83M52W Range6.97 - 11.22
Valley National Bancorp is a bank and financial holding company, which engages in the provision of retail and commercial banking services. It operates through the following segments: Commercial Banking, Consumer Banking, and Treasury and Corporate Other. The Commercial Banking segment includes commercial and industrial loans, and commercial real estate loans. The Consumer Banking segment refers to residential mortgage loans, other consumer loans, and wealth management. The Treasury and Corporate Other segment relate to treasury managed held to maturity and available for sale debt securities portfolios. The company was founded in 1927 and is headquartered in Morristown, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHILLURA JOSEPHSEVP, CML Banking PresidentMay 23 '24Sale7.4325,000185,75010,000May 28 04:11 PM
ABRAMSON ANDREW BDirectorMay 22 '24Sale7.7216,451127,002224,679May 23 12:28 PM
CHILLURA JOSEPHSEVP, CML Banking PresidentMar 11 '24Sale8.1849,715406,669545,249Mar 13 11:22 AM
WILLIAMS SIDNEY SDirectorJan 29 '24Buy10.376736,97921,605Jan 30 04:50 PM
CHILLURA JOSEPHSEVP, Chief Customer OfficerDec 08 '23Sale9.9550,000497,500541,235Dec 12 04:31 PM
PGC - Peapack-Gladstone Financial Corp. - Stock Price Chart
TickerPGC [NASD, RUT]
CompanyPeapack-Gladstone Financial Corp.
CountryUSA
IndustryBanks - Regional
Market Cap372.90MEPS (ttm)2.18
P/E9.64EPS this Y-30.75%
Forward P/E8.32EPS next Y34.46%
PEG8.03EPS past 5Y3.25%
P/S0.96EPS next 5Y1.20%
P/B0.64EPS Q/Q-51.77%
Dividend0.95%Sales Q/Q10.94%
Insider Own17.52%Inst Own69.86%
Insider Trans-0.29%Inst Trans-3.59%
Short Float3.38%EarningsApr 23/a
Analyst Recom1.67Target Price30.33
Avg Volume98.06K52W Range21.58 - 31.49
Peapack-Gladstone Financial Corp. is a bank holding company, which engages in the provision of private banking services to businesses, non-profits, and consumers. It operates through the Banking and Peapack Private segments. The Banking segment is involved in the delivery of loan and deposit products to customers. The Peapack Private segment focuses on asset management services for individuals and institutions. The company was founded in August 1997 and is headquartered in Bedminster, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vorcheimer Stuart M.EVP, Comm & Ind LndgMay 21 '24Sale24.094,608111,0072,205May 22 12:32 PM
Smith Gregory MartinSEVP, President Comml BankingJan 30 '24Sale30.024,500135,07815,703Jan 30 03:33 PM
Vorcheimer Stuart M.EVP, Comm & Ind LndgSep 06 '23Sale26.806,000160,8164,762Sep 07 04:32 PM
Cavallaro Frank A.SEVP & Chief Financial OfficerAug 01 '23Buy29.382,55875,1545,838Aug 04 04:32 PM
BABCOCK JOHN PSEVP & Pres of Priv Wealth MgtJun 07 '23Sale30.206,000181,17165,242Jun 08 10:24 AM
SEAT - Vivid Seats Inc - Stock Price Chart
TickerSEAT [NASD, RUT]
CompanyVivid Seats Inc
CountryUSA
IndustryInternet Content & Information
Market Cap630.21MEPS (ttm)0.10
P/E47.10EPS this Y-43.23%
Forward P/E12.94EPS next Y28.01%
PEG4.33EPS past 5Y-
P/S0.85EPS next 5Y10.88%
P/B4.61EPS Q/Q-28.94%
Dividend-Sales Q/Q18.50%
Insider Own45.19%Inst Own50.48%
Insider Trans-28.45%Inst Trans-6.21%
Short Float14.31%EarningsMay 07/b
Analyst Recom1.69Target Price9.38
Avg Volume1.66M52W Range4.86 - 8.80
Vivid Seats, Inc. operates as an online ticket marketplace, which engages in the provision of different selections of events and tickets in North America. It operates through the following segments: Marketplace and Resale. The Marketplace segment acts as an intermediary between event ticket buyers and ticket sellers. The Resale segment acquires tickets to resell on secondary ticket marketplaces, including its own. Its partners include Caesars Entertainment, RollingStone, Marriott Bonvoy, Capital One, American Airlines and others. The company was founded in 2001 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Epstein Emily TGeneral CounselMay 13 '24Sale5.551,3817,66534,243May 13 07:01 PM
Bakal RivaChief Strategy OfficerApr 22 '24Sale5.901,1366,70297,670Apr 23 05:59 PM
Pickus EdwardChief Accounting OfficerApr 22 '24Sale5.905373,16835,434Apr 23 05:58 PM
Wagner Jonathan MilesChief Technology OfficerMar 12 '24Sale5.7129,588168,947139,925Mar 13 04:26 PM
Bakal RivaChief Strategy OfficerMar 12 '24Sale5.712,05111,71194,955Mar 13 04:20 PM
1234567891017